The Deerborne Group: Disrupting the Status Quo

“Photo Credit: Shutterstock.com”

Startups are known for being some of the biggest disruptors within the broader life science sector — creating new and innovative technologies to diagnose, treat, and monitor a vast array of critical diseases. However, some seventy-five percent of venture-back startups fail to turn insights into value. Unfortunately, these startups are often driven by their technology instead of applying that technology to the unmet needs of the market. That’s where The Deerborne Group comes in. Their primary focus is advising corporations, venture capital, and private equity firms on commercial, operations, and corporate strategy. They help them identify opportunities, minimize risks, and how best to navigate their most difficult management challenges.

The Deerborne Group, a boutique management consulting firm, is located in San Diego’s north county; the third largest hub for biotech, in-vitro diagnostics, and life science innovation and research in the country. Founded in 2020, The Deerborne Group is comprised of industry leading consultants from across the globe. They combine their extensive expertise with first-hand knowledge to help their clients gain the strategic insights needed to identify and accelerate the development and commercialization of promising diagnostic solutions.

You may be asking yourself how is The Deerborne Group’s consulting model different than the status quo? When presented with a challenging and complex engagement, they don’t send “generalists” in, nor do they throw a handful of inexperienced, post-MBAs at the problem. Take their newly formed scientific advisory board (SAB) which is made up of internationally recognized key opinion leaders (KOL’s) who bring with them decades of knowledge and deep industry experience. This SAB serves as the foundation for their “Insights on Demand” virtual advisory service. As they continue to grow and differentiate the innovative and unique consulting services that they offer their clients, the Insights on Demand virtual advisory service fills an existing and growing gap in a post-COVID marketplace. Insights on Demand provides clients with virtual access to the collective expertise and strategic counsel of these KOL’s in a more straight forward and cost-effective manner.

Put simply, The Deerborne Group believes consultants should have a long history and be “subject matter experts” in the field that they are consulting in. Case in point, you won’t find them consulting on a wind turbine project in Dubai. Why, because that’s not their wheelhouse. That they happily leave to the status quo. The Deerborne Group focuses exclusively on biotechnology, in-vitro diagnostics, and the life sciences. That’s it! In fact, all their consultants come exclusively from these fields with decades of experience behind them. They combine their extensive expertise with their first-hand knowledge to help their clients gain the strategic insights needed to identify and accelerate the development and commercialization of promising solutions.

A recent example of this model in action was in 2021 when a private equity firm, that invests in molecular diagnostic businesses, was looking to add to their portfolio and retained The Deerborne Group’s services to help them with their due diligence in preparation for a possible investment. Based on The Deerborne Group’s extensive background in this market, an initial assessment was conducted to analyze the market opportunity in order to gain insights and identify potential risks. This included taking a deep-dive and looking at market conditions, regulatory, reimbursement, and the competition. To further understand the unmet needs of the customer, both qualitative and quantitative research was conducted with the industry’s KOL’s. During their onsite due diligence, consultants from The Deerborne Group conducted several audits that included an audit of their quality management system (QMS). In the end, a thorough analysis was delivered to the client that provided them with the insights needed to minimize risk, increase confidence, and make the most informed investment decision.

The above example is just one of many such engagements The Deerborne Group has entered since opening their doors two years ago. But it’s really their firsthand experience having worked in this market for decades that differentiates them and makes them so attractive to clients looking to break free from the status quo. Given their background, The Deerborne Group is able to make an immediate and positive impact in a more cost-effective and timely manner. You just don’t get that level of experience with the status quo.

So, if you’re looking at outsourcing a project that can only be approved by your board if you hire one of the large, big-box firms that make up the status quo, you can stop reading. But if you are looking for real world solutions to your most challenging problems, or simply an innovative alternative to the status quo, The Deerborne Group may just be that disruptive boutique management consulting firm that you didn’t know you needed.

About The Deerborne Group:

The Deerborne Group is a boutique management consulting firm that focuses exclusively on the global biotechnology, in-vitro diagnostics, and life sciences industries. Their primary focus is advising corporations, venture capital, and private equity firms on commercial, operations, and corporate strategy. They help clients identify opportunities, minimize risks, and how best to navigate some of their most difficult management challenges.

If you liked this blog, make sure to share it with your friends and colleagues. For more information, please visit The Deerborne Group or follow us on LinkedInFacebook, or Twitter. Copyright© 2022 | The Deerborne Group, Inc.